FDA says Epipens, Adrenaclicks in short supply

Top Stories
Epipens in short supply 05.09.18_1525878364712.PNG.jpg

EpiPens are in short supply in parts of the U.S., but people should still be able to find the emergency treatment for allergic reactions, federal health officials said Wednesday.

The Food and Drug Administration added EpiPens to its list of drug shortages, saying there have been supply disruptions even though the maker, Mylan, is still making and distributing EpiPens and a generic version.

The spot shortages don’t mean people cannot get EpiPens or generics, but they may have to look harder or turn to a different brand, the FDA said.

Click here for more

Copyright 2020 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

More Check This Out
Loving Living Local 600x600

Don't Miss